Elucidating the active delta-opioid receptor crystal structure with peptide and small-molecule agonists.
Claff, T., Yu, J., Blais, V., Patel, N., Martin, C., Wu, L., Han, G.W., Holleran, B.J., Van der Poorten, O., White, K.L., Hanson, M.A., Sarret, P., Gendron, L., Cherezov, V., Katritch, V., Ballet, S., Liu, Z.J., Muller, C.E., Stevens, R.C.(2019) Sci Adv 5: eaax9115-eaax9115
- PubMed: 31807708 
- DOI: 10.1126/sciadv.aax9115
- Primary Citation of Related Structures:  
6PT2, 6PT3 - PubMed Abstract: 
Selective activation of the δ-opioid receptor (DOP) has great potential for the treatment of chronic pain, benefitting from ancillary anxiolytic and antidepressant-like effects. Moreover, DOP agonists show reduced adverse effects as compared to μ-opioid receptor (MOP) agonists that are in the spotlight of the current "opioid crisis ...